Search
for
Sort by
Research 91–120 of 1000+
- Pathology in Practice
- Guidelines for the Use of Acitretin in Psoriasis
- Thionamide-Responsive Alopecia Areata in a 11 Year Girl
- The Role of Herbal Medicine in Breast Cancer Treatment: Evidence for Therapeutic Effectiveness
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Symptom management in inflammatory bowel disease
- Cutaneous Reactions to Drugs
- Niosomes as a propitious carrier for topical drug delivery
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Psychoactive drugs and skin
- Drug-Induced Skin, Nail and Hair Disorders
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Drug-induced acne
- New drugs under investigation for the treatment of alopecias
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Cutaneous drug reactions
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Drug Reactions Affecting Hair: Diagnosis
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- An Update on Drug-Induced Pigmentation
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Hair Changes due to Drugs
- Hair Loss Effects and Surgical/Drug Treatments for the Alopecias
- Absorption sites of orally administered drugs in the small intestine
- Clinical Development of Topoisomerase-Interactive Drugs
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata